ARCHIVES

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Advocacy Group Amasses Support For Bill That Threatens Integrity of NCI Peer Review

August 3, 2012

Meharry, Vanderbilt Win Grant For Research Collaboration.

March 30, 2001

In Brief: Three More Comprehensive Centers May Be Names; Hawaii, Cleveland, Ohio State Lead List of 10

May 9, 1975

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

November 3, 1989

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

January 26, 2001

Conversation With The Cancer Letter: Wicha to Leave Director’s Job at UMich

November 8, 2013